Cargando…

The Prognostic Value of Epigenetic Silencing of p16 Gene in NSCLC Patients: A Systematic Review and Meta-Analysis

BACKGROUND: The prognostic significance of p16 promoter hypermethylation in patients with non-small cell lung cancer (NSCLC) is still controversial. This analysis presents pooled estimates of the association to better elucidate whether p16 methylation has a prognostic role in NSCLC. METHODS: Relevan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lou-Qian, Zhang, Rong, Yin, Ming, Li, Xin, Yang, Feng, Jiang, Lin, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555860/ https://www.ncbi.nlm.nih.gov/pubmed/23372805 http://dx.doi.org/10.1371/journal.pone.0054970

Ejemplares similares

Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis
por: Zhang, Lou Qian, et al.
Publicado: (2012)

Prognostic Value of Overexpressed p16(INK4a) in Vulvar Cancer: A Meta-Analysis
por: Cao, Hanyu, et al.
Publicado: (2016)

The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis
por: Xing, Xiang-Bin, et al.
Publicado: (2013)

The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis
por: Chen, Engeng, et al.
Publicado: (2016)

Frequent Epigenetic Silencing of the p16 Gene in Non‐small Cell Lung Cancers of Tobacco Smokers
por: Yanagawa, Naoki, et al.
Publicado: (2002)

Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types
por: Vrba, Lukas, et al.
Publicado: (2018)

Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis
por: Wu, Yongming, et al.
Publicado: (2023)

Letter regarding “The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis”
por: Jiang, Mingyang, et al.
Publicado: (2019)

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact
por: Li, Zhenhai, et al.
Publicado: (2019)

Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC
por: Yu, Hongliang, et al.
Publicado: (2020)

METH-2 silencing and promoter hypermethylation in NSCLC
por: Dunn, J R, et al.
Publicado: (2004)

Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
por: Yue, Jinnan, et al.
Publicado: (2018)

Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC
por: Yang, Qin, et al.
Publicado: (2022)

Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration
por: Cai, Dechao, et al.
Publicado: (2022)

Nickel and Epigenetic Gene Silencing
por: Sun, Hong, et al.
Publicado: (2013)

Epigenetic silencing in transgenic plants
por: Rajeevkumar, Sarma, et al.
Publicado: (2015)

Prognostic Value of BIM Deletion in EGFR-Mutant NSCLC Patients Treated with EGFR-TKIs: A Meta-Analysis
por: Lv, Fangfang, et al.
Publicado: (2021)

Response: Letter regarding “The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis”
por: Sand, Freja Lærke, et al.
Publicado: (2019)

Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma
por: Ming, Fei, et al.
Publicado: (2017)

Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis
por: Hong, Xiaohua, et al.
Publicado: (2022)

Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD
por: Mi Woo, Yu, et al.
Publicado: (2015)

The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis
por: Sun, Guorui, et al.
Publicado: (2017)

Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis
por: Zhou, Ning, et al.
Publicado: (2018)

FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC
por: Hu, Dong-Mei, et al.
Publicado: (2022)

Histone chaperone Spt16p is required for heterochromatin mediated silencing in budding yeast
por: Yan, Xiaowei, et al.
Publicado: (2017)

Upregulation of long noncoding RNA Xist promotes proliferation of osteosarcoma by epigenetic silencing of P21
por: Xu, Tianyang, et al.
Publicado: (2017)

Epigenetic Silencing of DKK3 in Medulloblastoma
por: Valdora, Francesca, et al.
Publicado: (2013)

Durable CRISPR-Based Epigenetic Silencing
por: Nakamura, Muneaki, et al.
Publicado: (2021)

Prognostic value of miR-17-5 p in gastrointestinal cancers: a systematic review and meta-analysis
por: Wang, Zeyu, et al.
Publicado: (2018)

The prognostic value of PCNA expression in patients with osteosarcoma: A meta-analysis of 16 studies
por: Wang, Xing, et al.
Publicado: (2017)

EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression
por: Guo, Yuan, et al.
Publicado: (2021)

Epigenetic silencing of miR-145-5p contributes to brain metastasis
por: Donzelli, Sara, et al.
Publicado: (2015)

The Prognostic Value of HPV Status and p16 Expression in Patients with Carcinoma of the Anal Canal
por: Roldán Urgoiti, Gloria B., et al.
Publicado: (2014)

Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR
por: Li, Tao, et al.
Publicado: (2023)

Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients
por: Yu, Dangfan, et al.
Publicado: (2013)

Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
por: Zhang, Chengjuan, et al.
Publicado: (2017)

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)

Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer
por: Ding, Wen, et al.
Publicado: (2015)

Telomeric Trans-Silencing: An Epigenetic Repression Combining RNA Silencing and Heterochromatin Formation
por: Josse, Thibaut, et al.
Publicado: (2007)

Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors
por: LIU, SHUZHENG, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2ut9obmj91nujt36ldat9l0ld6